Are you Dr. Schwarz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-4015
Summary
- Dr. James Schwarz, MD is an oncologist in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, New York, and Missouri. He is affiliated with Nebraska Medicine - Nebraska Medical Center, Nebraska Medicine - Bellevue, and Memorial Community Hospital and Health System.
Education & Training
University of Missouri-ColumbiaFellowship, Hematology and Medical Oncology, 1998 - 2001
Duke University HospitalFellowship, Infectious Disease, 1990 - 1994- Duke University HospitalResidency, Internal Medicine, 1987 - 1990
Duke University School of MedicineClass of 1987
Certifications & Licensure
NE State Medical License 2008 - 2026
MO State Medical License 1998 - 2021
NY State Medical License 2001 - 2008
NC State Medical License 1989 - 1995- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 40 citationsCabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain EndpointEthan Basch, Mark C. Scholz, Johann S. de Bono, Nicholas J. Vogelzang, Paul de Souza
European Urology. 2019-06-01 - 355 citationsE2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.Timothy F. Kowalik, James DeGregori, James K. Schwarz, Joseph R. Nevins
Journal of Virology. 1995-04-01 - 228 citationsUse of the green fluorescent protein as a marker in transfected Leishmania.D. Sean Ha, James K. Schwarz, Salvatore J. Turco, Stephen M. Beverley
Molecular and Biochemical Parasitology. 1996-04-01
